SCHEMBL9942597

SCHEMBL9942597

Bc1ncc(F)c2c(C(=O)C(=O)N3CCN(C(=O)c4ccccn4)CC3C)c[nH]c12

nearest known ligand 0.51

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 5/20 0.51
CYP2D6 P10635 4/20 0.51
CYP2C9 P11712 4/20 0.51
CYP3A4 P08684 1/20 0.49
SMN1; SMN2 Q16637 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.39
GHSR Q92847 5/20 0.39
CHRNB2 P17787 1/20 0.37
CHRNB4 P30926 1/20 0.37
CHRNA3 P32297 1/20 0.37
CHRNA7 P36544 1/20 0.37
CHRNA4 P43681 1/20 0.37
HRH3 Q9Y5N1 1/20 0.35
GAA P10253 1/20 0.35
DPP4 P27487 1/20 0.35
DPP9 Q86TI2 1/20 0.35
RBP4 P02753 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2633280 0.91 CYP2C19 (0.51) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL1763119 0.91 CYP2C19 (0.51) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL2629068 0.87 CYP2C19 (0.51) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL6445636 0.87 CYP2C19 (0.51) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL7073321 0.87 CYP2C19 (0.51) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL13639699 0.84 CYP2C19 (0.59) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL9942600 0.84 CYP2C19 (0.59) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL6441531 0.84 CYP2C19 (0.51) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL6441429 0.84 CYP2C19 (0.49) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2
SCHEMBL6471735 0.84 CYP2D6 (0.53) CYP2C19CYP2D6CYP2C9CYP3A4SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1363705-B9 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2012-11-07 EP disclosed
EP-1363705-B1 COMPOSITION AND ANTIVIRAL ACTIVITY OF SUBSTITUTED AZAINDOLEOXOACETIC PIPERAZINE DERIVATIVES BRISTOL MYERS SQUIBB CO (US) 2012-06-13 EP disclosed